Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 94 results found. Search for [ COVID-19 vaccine J ]

Results 40 to 60 of 94
Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


Reuters
September 5, 2020
J&J's vaccine is one of over a hundred worldwide being developed in response to the coronavirus pandemic, which has infected nearly 26.5 million people and led to some 869,323 deaths


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


Reuters
September 1, 2020
Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials


PTI
August 25, 2020
Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the Covid-19 vaccine candidate, developed by the University of Oxford


BusinessToday.In
August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19


Reuters
August 15, 2020
Britain and the United States are in the lead with six vaccine deals with drugmakers each, as companies and governments worldwide work overtime to find a vaccine against the pandemic disease


Reuters
August 14, 2020
J&J aims to produce more than 1 billion doses of its vaccine candidate, and has struck a similar deal with U.S.-based Emergent BioSolutions Inc to boost manufacturing


PTI
August 7, 2020
The company has successfully completed the Phase-I and Phase II studies. Phase-III clinical study is expected to be initiated by December 2020.


PTI
August 7, 2020
The researchers from National Research University Higher School of Economics (HSE) in Russia noted that the structural elements of the novel coronavirus that are less subject to mutation during its evolution should be chosen as a target for the potential treatment


BusinessToday.In
New Delhi, August 7, 2020
Microsoft aims to buy TikTok's entire global businessMicrosoft Corp is chasing a deal to buy all of TikTok's global business. However, a source familiar with the discussions told Reuters that Microsoft had not raised the prospect of buying all of TikTok in its negotiations with ByteDance. Microsoft had said it was seeking to buy the assets of TikTok in North America, Australia and New Zealand.COVID-19 vaccine: US to pay $1 billion for 100 million doses of J&J's potential candidateThe U...


Reuters
August 7, 2020
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March


PTI
August 3, 2020
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa


BusinessToday.In
July 31, 2020
Coronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workers


Reuters
July 30, 2020
The drugmaker said it had started early-stage human trials in the United States and Belgium and would test its vaccine candidate in over 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and older


Reuters
July 24, 2020
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to be safe and effective in a large pivotal clinical trial expected to start this month


BusinessToday.In
July 21, 2020
Maharashtra continues to remain the worst-hit Indian sate from coronavirus. The state reported 8,240 fresh cases of corona since yesterday, taking the total tally to 3,18,695


BusinessToday.In
July 17, 2020
Coronavirus vaccine news update: Zydus Cadila Chairman Pankaj Patel has said that he expects a potential COVID vaccine to be out in the market by early next year


BusinessToday.In
July 17, 2020
India has so far conducted 127,39,490 COVID-19 tests, including 3,26,826on Thursday alone; this is the seventh consecutive day that COVID-19 cases have increased by over 26,000, which can be attributed to higher number of daily tests


Reuters
July 7, 2020
The announcement follows a $456 million investment in Johnson & Johnson's vaccine candidate in March, a $486 million award to Moderna Inc in April, and up to $1.2 billion in support in May for AstraZeneca's vaccine being developed with Oxford University


PAGES 3 OF 5  12345